HOERSHOLM, Denmark--(BUSINESS WIRE)--Santaris Pharma, a clinical stage biopharmaceutical company, pioneering LNA-antisense drugs, today announced that CEO Søren Tulstrup will present a company overview at the Rodman & Renshaw 10th Annual Healthcare Conference on November 11 at 5.20 p.m. ET at the New York Palace Hotel in New York City (Adams Room).
